What is ESLAW's market cap?

$155.49K, based on the Nov 12 close of $0.07.

What sector is ESLAW in?

Healthcare, in the Biotechnology industry.

NASDAQ · ESLAWHealthcareBiotechnology

Estrella Immunopharma, Inc. Warrant (ESLAW)

$0.0702+12.32%

Close Nov 12, 2026 · split-adjusted

Nov 9, 2026$0.06▼ 50.00% in range

Nov 12, 2025Low $0.05 · High $0.14Nov 9, 2026

What changed · written from our data

As of Nov 12, 2026

Estrella Immunopharma, Inc. Warrant closed at $0.07 on Nov 12, up 12.32%, 50.3% below its highest close since Oct 2. Volume of 10.0K shares was 1.93× its 20-day average (above normal).

Short interest was 23.7K shares at the Oct 30 settlement (7.6 days to cover).

Market cap$155.5K2.2M shares

Revenue · quarter$0.00—

Diluted EPS$-0.05—

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Oct 20.05 – 0.14−50.3% from high

Volume10.0K1.93× 20-day avg

Volatility · 60d292.2%Annualised

Short % of float—7.6 days to cover

Net cash$146.7KCash $146.7K

Next earnings—Not scheduled

Split-adjusted performance

1W −12.1%1M —3M +0.6%6M —YTD +40.4%1Y —3Y +40.4%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 138 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −24.9%, revenue growth +4.6%, net margin −228.7%, P/E 19.3×.

Short interest

Details →

Shares short23.7K0.0% vs prior

Days to cover7.6Settled Oct 30

% of float—

Short vol. 10d97.5%of daily volume

Closest peers by size in Biotechnology

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ESLAWEstrella Immunopharma, Inc. Warrant	$0.0702	+12.32%	—	—	—	—	$155.5K
TVGNWTevogen Inc. Warrant	$0.0412	+0.49%	−2.6%	—	—	—	$740.6K	Compare
RVMDWRevolution Medicines, Inc. Warrant	$8.15	−5.78%	+45.8%	—	−206.2%	—	$90.0M	Compare

News about Estrella Immunopharma, Inc. Warrant

All news →

ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. StockholdersGlobeNewswire Inc. · Jul 9, 2026▼ Negative

Quick answers

What does Estrella Immunopharma, Inc. Warrant do?: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
What is ESLAW's market cap?: $155.49K, based on the Nov 12 close of $0.07.
What sector is ESLAW in?: Healthcare, in the Biotechnology industry.

About Estrella Immunopharma, Inc. Warrant

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

HQ: Emeryville, CAListed Oct 2, 2023estrellabio.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology